HighTower Advisors’s Elanco Animal Health Incorporated 5.00% Tangible Equity Units ELAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-9,558
Closed -$200K 3589
2022
Q3
$200K Hold
9,558
﹤0.01% 2614
2022
Q2
$307K Sell
9,558
-531
-5% -$20K ﹤0.01% 2347
2022
Q1
$413K Buy
10,089
+60
+0.6% +$2.51K ﹤0.01% 2311
2021
Q4
$450K Sell
10,029
-2,867
-22% -$138K ﹤0.01% 2230
2021
Q3
$640K Buy
+12,896
New +$672K ﹤0.01% 1910

Other funds holding ELAT

HighTower Advisors's ELAT Position: Q4 2022 in Review

HighTower Advisors sold out of Elanco Animal Health Incorporated 5.00% Tangible Equity Units (ELAT) in Q4 2022, closing a stake of 9,558 shares — an estimated $200K sold.

HighTower Advisors first reported a position in ELAT in Q3 2021 and held it in 5 quarters. The position peaked at $640K in Q3 2021. 27 funds tracked by Wall St. Rank hold ELAT as of Q4 2022.

  • HighTower Advisors reported no remaining Elanco Animal Health Incorporated 5.00% Tangible Equity Units position as of Q4 2022 after selling out during the quarter.
  • HighTower Advisors sold 9,558 Elanco Animal Health Incorporated 5.00% Tangible Equity Units shares in Q4 2022, an estimated $200K.
  • HighTower Advisors first reported a position in Elanco Animal Health Incorporated 5.00% Tangible Equity Units in Q3 2021 and held it in 5 quarters.
  • HighTower Advisors's Elanco Animal Health Incorporated 5.00% Tangible Equity Units position peaked at $640K in Q3 2021.
  • 27 funds tracked by Wall St. Rank held Elanco Animal Health Incorporated 5.00% Tangible Equity Units as of Q4 2022.

Based on HighTower Advisors's 13F filing for Q4 2022, filed 9 Feb 2023.